Company news
Keen Vision Acquisition Corporation (NASDAQ:KVAC) news
Keen Vision Acquisition Corporation news releases on 6ix. Latest, Jul 15, 2025: Medera and University of Kansas Medical Center Announce First Patient Treated…
Press releases & updates
Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy
July 15, 2025
Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome
June 24, 2025
Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress
May 19, 2025
Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress
May 12, 2025
Keen Vision Acquisition : Financial Obligation Form 8 K
November 26, 2024
Keen Vision Acquisition : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)
November 4, 2024